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Summary.-The combination of hyperthermia and the hypoxic cell radiosensitizer
Ro-07-0582 has been investigated on the EMT6 tumour implanted into the legs of
BALB/c mice. Treatments at a drug dose of 1 mg/g over a range of waterbath
temperatures from 37 to 45°C are described. The surviving clonogenic fraction
following treatment was assayed in vitro. Measurements of intra-tumour tempera-
ture have been made, and shown to be better correlated with the cytocidal effect on
the tumour than the waterbath temperature.
No significant effect of Ro-07-0582 was observed at 37°C. However, marked
cytotoxicity due to the drug was seen at intra-tumour temperatures above 42 5°C for
1 h. These were in addition to the cytocidal effect of the hyperthermia. The results
are discussed in relation to the distribution of temperatures and hypoxic cell popu-
lations throughout the tumour.
IT is thought likely that the presence
of hypoxic cells in tumours may contri-
bute towards the failure of cure by radio-
therapy. Recent work on drugs which
increase the radiosensitivity of hypoxic
cells has been directed at this problem
(reviewed by Adams, 1973). The nitro-
imidazoles appear to be a particularly
promising group ofagents, and ofthese the
2-nitroimidazole (1-(2-nitroimidazol-l-yl)-
3-methoxy-2-propanol), designated Ro-07-
0582, has been most extensively investi-
gated, as reviewed by Adams and Fowler
(1976). Evidence is also now accumu-
lating that these imidazole compounds
may be selectively cytotoxic for hypoxic
cells (Sutherland, 1974; Hall and Roizin-
Towle, 1975; Mohindra and Rauth, 1976;
Foster et al., 1976; Brown, 1975; Suther-
land et al., 1976).
There is also much current interest in
the possible role of hyperthermia as a
method for cancer therapy. Treatment
by temperatures in excess of 41 50C may
produce cell killing, as reviewed by Suit
and Shwayder (1974), Har-Kedar and
Bleehen (1976), Thrall et al. (1976) and
Bronk (1976). Synergistic effects have
been described when hyperthermia is
combined with chemotherapy (Hahn,
Braun and Har-Kedar, 1975) and re-
viewed by Har-Kedar and Bleehen (1976),
and Dickson and Suzangar (1976). Evi-
dence has also been presented that cell
killing by hyperthermia may be enhanced
by hypoxia (Gerweck, Gillette and Dewey,
1974; Kim, Kim and Hahn, 1975a) and
that a significant reduction in oxygen
enhancement ratio (OER) may be ob-
tained when irradiated cells are subse-
quently treated for 2 h at 42°C (Kim, Kim
and Hahn, 1]975b).
In this paper we present data obtained
during experiments investigating the com-
bination ofhyperthermia and the hypoxic
cell sensitizer Ro-07-0582 on the EMT6
mouse mammary tumour treated in vivo.
Brief preliminary details have already
been reported (Bleehen, Honess and
Morgan, 1976).
MATERIALS AND METHODS
Aninmals.-Male BALB/c mice between
10 and 14 weeks of age, and weighing 20 to
25 g were used.N. M. BLEEHEN, D. J. HONESS AND J. E. MORGAN
Tumours.-The EMT6 tumour was first
described by Rockwell, Kallman and Fajardo
(1972). The particular subline used for this
work was designated EMT6/VJ/AC and was
originally supplied to us by Dr E. Frindel.
The line is maintained by alternating growth
as a solid tumour in vivo with 4 passages
in vitro.
Tumours were produced for these experi-
ments by i.m. injection of 4 x 104 tumour
cells, in a volume of0 05 ml, into the left hind
leg of the mouse. Animals were used at
Day 8-10 after tumour inoculation.
Assay ofsurvivingfraction.-Immediately
after treatment, the animals were killed and
the tumours were excised in toto (except
where otherwise stated) weighed, and finely
minced with scissors. A cell suspension was
prepared by trypsinisation, and the assay for
surviving fraction for individual tumours
carried out as previously described (Twenty-
man and Bleehen, 1974). Plating efficiencies
of cells obtained from untreated tumours
varied between 30% and 65% in these
experiments.
Drugs.-Ro-07-0582 (Roche Laboratories)
was used throughout this work at a dose of
1-0 mg/g body wt. of mouse. The drug was
dissolved in Hanks' balanced salt solution at
a concentration of 25 mg/ml, and each mouse
was given the appropriate volume as an i.p.
injection. This dose of sensitizer proved
lethal to 12% of the mice anaesthetized
during the experiments. The dose of Ro-07-
5082 was routinely given at the start of
heating, except when otherwise stated.
Heat treatment.-Mice were anaesthetized
with sodium pentobarbitone (Nembutal),
injected i.p. at an initial dose of 0-06 mg/g
for control animals and 0-04 mg/ml for
Ro-07-0582 treated animals. The anaes-
thetic dose was reduced for the sensitizer-
treated animals because of the potentiating
effect of the sensitizer on the level of anaes-
thesia. Tumours were heated for 1 h by
immersion ofthe hind leg bearing the tumour
in a thermostatically-controlled circulating
waterbath (Grant Ltd.). A booster dose of
anaesthetic was usually required to maintain
anaesthesia for 1 h.
Intra-tumour temperatures weremeasured
by needle thermistor probes in association
with a multichannel direct-reading electric
thermometer (Light Laboratories Ltd).
Needle probes of0-82 mm diameter containing
a thermistor bead at 3 mm from the tip were
used. The probes were inserted into the
flank ofthe animal above the water level and
passed, subcutaneously, down to the tumour,
in an attempt to avoid major errors due to
heat conduction along the probe. The end
of the probe which contained the thermistor
bead was routinely sited as near as possible
to the centre ofthe tumour. Some measure-
ments were carried out to investigate
temperature variation across the tumour.
The temperature of the tumours was found
to rise rapidly during the first 5 min to within
0-5°C of the final temperature. In some
animals it continued to rise slowly over the
subsequent 5 min. The rectal temperature
never rose above 39°C. The temperature
given as " intra-tumour temperature " in all
cases refers to the final peak temperature.
The presence of the probe in the tumour
did cause some bleeding, which was exacer-
bated at higher temperatures. It should be
noted that the tumour masses recorded
include the blood and clots where these
occurred, and that in general the higher the
waterbath temperature, the more hyperaemic
the tumour appeared to be.
RESULTS
Fig. 1 shows composite data for a
series of experiments in which tumours
were heated for 1 h at waterbath tempera-
tures of 42°, 430, 440 and 45TC, with the
surviving fraction (SF) plotted against
waterbath temperature. At waterbath
temperature 45°C a considerable enhance-
ment ofcellkilling inducedby the presence
of Ro-07-0582 is seen, though the magni-
tude of this cell killing varies consider-
ably. An enhancement of cell killing in
the presence ofRo-07-0582 is seen in some
tumours at waterbath temperatures of
44TC, but not others, and the spread of
points at this temperature is even greater.
At 43°C waterbath temperature the points
for treated and untreated tumours lie over
the same range. The same is true at
42TC, although the range is smaller,
reflecting the smaller degree of killing by
heat alone at these lower temperatures.
The data have been subjected to a one-
sided Wilcoxon-Mann-Whitney test.
This shows that at 45TC waterbath
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FIG. 1.-Composite data for survivingfraction
of EMT6 tumour cells treated for 1 h at
waterbath temperatures of42-45°C. Each
point represents a single tumour. Lines
have been drawn through medians. 0,
Heat alone; 0, Ro-07-0582 (1 mg/g) at
start of heat treatment.
temperature the SF following drug treat-
ments are significantly different from the
controls at the 99% confidence level.
However, for the 440C waterbath data,
the distribution ofpoints is such that there
is no evidence for a significant difference.
The same is true for lower waterbath
temperatures.
Fig. 2 shows composite results for the
series of experiments where intra-tumour
measurements were made with SF plotted
againstintra-tumourtemperature. Fewer
experiments have been performed with
these intra-tumour measurements than
the total number of experiments in this
series. The data demonstrate that the
toxic effect of Ro-07-0582 is marked at
intra-tumour temperatures of more than
42*5°C, whereas at intra-tumour tempera-
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Fie. 2.-Composite data for surviving fraction
ofEMT6 tumour cells treated for 1 hplotted
against intra-tumour temperature. Each
point represents a single tumour. Vertical
dashed line represents intra-tumour tem-
perature of 42-5°C. 0, Heat alone; 0,
Ro-07-0582 (1 mg/g) at start of treatment.
tures of less than 42-50C there is no
apparenteffect. Theone-sidedWilcoxon-
Mann-Whitney test on the data expressed
in this manner shows a significant dif-
ference between drug-treated and control
tumours, at better than the 99% con-
fidence level, for intra-tumour tempera-
tures above 42-50C. There is no evidence
for any such difference below 42-5°C.
This cut-off temperature was selected for
this test because we have unpublished
evidence for our cells in vitro that 42 50C
is the threshold temperature for cytocidal
effects after 1 h exposure to the drug.
Since there was a variation in observed
intra-tumour temperatures between tum-
ours in the same waterbath, an attempt
has been made to correlate this with a
measurable tumour parameter, namely
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mass of excised tumour. However, the
calculated correlation coefficient of 0-15
for a waterbath temperature of 430C
illustrates that there is no correlation
between measured intra-tumour tempera-
ture and tumour size. Correlation co-
efficients for the other temperatures show
a similar lack of correlation.
It was observed that the temperature
at the outside of the tumour was usually
higher than that in the centre of the
tumour. This varies from tumour to
tumour, but the greatest recorded dif-
ference was 0.6C0. A series of experi-
ments was therefore performed to investi-
gate the effect ofthis temperature gradient
on the SF of drug-treated and control
tumours. It was, however, necessary to
perform these experiments without con-
current intra-tumour temperature meas-
urements, since the needle detector caused
bleeding within the tumour, and it was
desirable to maintain the integrity of the
tumour during heating, to allow sub-
sequent selection of tumour material for
assay. Samples not exceeding 2 mm in
thickness were taken from the periphery
and centre of tumours. It was not found
possible to collect the remainder of the
tumour after taking two samples, so an
estimate of total tumour mass was not
made. The results for a series of experi-
ments at 440C waterbath temperature are
shown in Fig 3. Thirteen of the 15
tumours examined showed a lower SF for
cells from the periphery than from the
centre, which is in accordance with the
observation that the periphery normally
reaches a higher temperature. These
results also show a marked effect of the
Ro-07-0582, and for this data the
Wilcoxon-Mann-Whitney test shows that
the drug-treated tumours are significantly
different from the controls, at the 99%
confidence level, both for central and
peripheral tumour assays.
A similar trend, but of lesser magni-
tude, is seen at a waterbath temperature
of 4300.
Experiments were also carried out to
investigate the effect of the timing of the
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FIG. 3.-Surviving fraction of centre and
peripheral parts of EMT6 tumour treated
for 1 h at 44°C waterbath temperature.
Vertical line connects results from indivi-
dual tumours. A, Centre of tumour, heat
alone; Lii, Periphery of tumour, heat alone;
A, Centre of tumour, heat + Ro-07-0582
*, Periphery of tumour, heat + Ro-07-
0582.
drug on the development of cytocidal
effect. Samples of tumour from two
animals were pooled for the estimation of
SF in this series. The drug was admini-
stered either 30, 60 or 90 min before the
end of a 60-min period ofheating. Fig. 4
shows composite data for the experiments
at 4400 waterbath temperature. The
results indicate that the cytotoxic effect
is not seen after only 30 min exposure to
the drug, but has developed after 60 min.
There is no observable increase in magni-
tude of the effect between 60 and 90 min.
No cell killing by Ro-07-0582 was seen in
2 experiments when the drug was admini-
stered immediately after the period of
hyperthermia and those animals killed
1 h later.
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FIG. 4. Composite data from experiments in
which duration of exposure to Ro-07-0582
was varied. Duration ofheat at waterbath
temperatures of 37°C and 44°C was 1 h in
all cases. A, 37°C alone; +, 37°C +
Ro-07-0582; 0, 44°C alone; 0, 44°C +
Ro-07-0582.
DISCUSSION
The data presented in this paper
demonstrate a potentiating effect ofhyper-
thermia on the cytotoxic effect of Ro-07-
0582 under the experimental conditions
employed.
In vitro cytotoxicity to metronidazole
(2-methyl-5-nitroimidazole-1-ethanol) has
been reported by Sutherland (1974) and
Mohindra and Rauth (1976) and, in vivo,
by Inch and McCredie (1975) and Foster
et al. (1976). In vitro hypoxic cell
cytotoxicity of Ro-07-0582 has been
reported by Sutherland et al. (1976) and
Hall and Roizin-Towle (1975).
In vivo cytotoxicity of Ro-07-0582 has
been demonstrated by Denekamp and
Harris (1975) using the NT tumour.
They reported a 10-25% increased delay
in tumour growth when Ro-07-0582 was
given after radiation when compared with
radiation alone. Brown (1975) reported
cytotoxicity of Ro-07-0582 on both the
MDAH/MCa4 tumour and the EMT6
tumour, at the same dose level of 1 mg/g
mouse body wt. as used in the work
reported here. He also reports unpub-
lished data that cytotoxicity does not
occur if there are no hypoxic cells in the
tumour.
We have not demonstrated any sig-
nificant cytotoxicity of Ro-07-0582 on the
EMT6 tumour at 37°C, even though the
hypoxic cell fraction of this tumour is
around 30°/% (Rockwell and Kallman,
1973; Bleehen, Har-Kedar and Watson,
unpub.). There are various possible ex-
planations for this apparent anomaly. If
all the hypoxic cells were killed by an
acute exposure to the drug, the resulting
expected average surviving fraction of 0 7
would be difficult to detect with precision
because of the considerable variation
between tumours. Certainly any smaller
degree of cell killing would not be seen, as
a result of this variation. Our technique
for a solid tumour differs from that ofmost
of the previously mentioned authors
investigating the cytotoxicity of the
hypoxic cell sensitizers, in that tumour
cells are removed from the animal immedi-
ately after the completion of the 1-h
exposure in the water bath. The sur-
viving fraction is then assayed in vitro.
Only Brown (1975) has used this in vivo-
in vitro method. He reports that the
cytotoxicity of Ro-07-0582 that he ob-
served with the EMT6 tumour does not
occur ifthe tumours are removed from the
animals within 1 h of injection.
This then raises a further possible
explanation for the apparent anomaly,
which may relate to the change with time
of the concentration of the drug in the
serum and in the hypoxic cells of the
tumour. We do not have any data on this
matter, but do observe peak radiosensi-
tization of the tumour in both air-
breathing and the hypoxic state within
30 min of administration of the drug
(Bleehen et at., unpub.). Adams and
U.vuuv
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Fowler (1976) reported that the half-life
of Ro-07-0582 in mice is around 1-1 h.
So it may be that exposure for several
hours, even though the serum level is
declining, is necessary to achieve detect-
able cytotoxicity. The in vitro work of
Hall and Roizin-Towle (1975) demon-
strated such a time-dependent cytotoxi-
city with Ro-07-0582.
A further observation should be made
concerning the estimate of hypoxic cell
fraction of around 30% in the EMT6
tumour (Rockwell and Kallman, 1973;
Bleehen et al., unpub.). These estimates
were based on the radiation treatment of
tumours in vivo followed by assay of cell
survival in vitro. McNally (1975) has
shown, with Sarcoma F in CBA mice, that
this technique may considerably over-
estimate the hypoxic cell fraction, relative
to that obtained from growth delay curves.
Such an analysis for the EMT6 tumour is
not really possible. Growth delay esti-
mations with the EMT6 tumour do
demonstrate a greater sensitivity to radi-
ation than might be expected on the basis
of cell-survival curves (Rockwell and
Kallman, 1973). However, this may be
related to the immunogenicity of the
tumour, and makes invalid a comparison
of the data similar to that of McNally
(1975).
The effect of hyperthermia over the
range of temperatures described in this
paper is consistent with the observations
of numerous previous authors, as reviewed
by Suit and Shwayder (1974) and Har-
Kedar and Bleehen (1976). The heat
sensitivity of EMT6 tumour cells in vitro
has been reported by Hahn et al. (1975),
Kal, Hatfield and Hahn (1975), Kal and
Hahn (1976). In vivo hyperthermia
studies with this tumour have been
carried out by Hahn et al. (1975), Kal and
Hahn (1976), Miller, Veomett and Gerner
(1976). The cytotoxic effect of hyper-
thermic treatment is dependent on both
temperature and exposure time. We have
not investigated this aspect extensively in
the present work, but selected a fixed
duration of 1 h hyperthermia over a
waterbath temperature range which spans
a measurable cell survival. The highest
temperatures of 44-450C result in some
normal tissue damage in the limbs when
animals are allowed to survive. The
maximum skin reaction is similar to that
seen in animals treated with 2100 rad
breathing air at room temperature, but
with a more evanescent time course. This
reaction is compatible with long-term
survival of the animal. However, tem-
peratures above 45°C result in unaccept-
able morbidity.
A temperature gradient between tum-
our and waterbath for the EMT6 tumour
in legs has been observed by other
workers (Hahn et al., 1975; Kal and Hahn,
1976). This inhomogeneity of tempera-
ture has obvious experimental disadvan-
tages.
The presence of this gradient across
the tumour may also be of significance
because of the possibility of a differential
sensitivity to heat at these sites. It is
known that a difference in pulse-labelling
index (LI) may be observed across
tumours. Thishasbeenrelatedtochanges
in nutritional and oxygenation status
(Hermens and Barendsen, 1969). A simi-
lar difference in LI is seen for the EMT6
tumour (Rockwell et al., 1972; Rockwell,
Frindel and Tubiana, 1976) and con-
firmed in ourlaboratory (Watson, unpub.).
It is also possible that there may be
differences inthe magnitude ofthe hypoxic
cell fraction in our tumour over the range
of sizes investigated, as reported with
other tumours (Suit and Maeda, 1967;
Peters, 1976).
A gradient of hypoxic cells across the
tumour may be of significance in this
series of experiments when (1) this results
in differences in plating efficiency of cells
viable in terms of trypan blue exclusion,
(2) if there is a concentration gradient of
Ro-07-0582, (3) or when there is a signifi-
cant temperature gradient.
We do not believe that the first two
possibilities are of significance. We have
not observed any difference in the plating
efficiency of tumour cells from the peri-
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phery or centre of tumours at 37°C.
Ro-07-0582 is freely diffusible and only
slowly metabolized (Adams and Fowler,
1976) and full radiosensitization by the
drug ofhypoxic cells in EMT6 tumours (in
the flank) has been reported (Brown, 1975;
Bleehen et al., unpub.).
The presence ofa temperature gradient
across the tumour is of more significance.
Small changes in temperature over the
range 42-45°C may produce large changes
in cell killing. It has also been reported
that hypoxic cells are more sensitive to
killing by heat than in oxic cells (Gerweck
et at., 1974; Kim et at., 1975a). The
surviving fractions assayed in this paper
will therefore be a product ofthe tempera-
ture and hypoxic cell gradients.
Our observation that the combination
of hyperthermia and Ro-07-0582 may
produce a considerable cell killing in vivo
has been confirmed by us with the EMT6
cell line in monolayer cultures (unpub.
data) and by Stratford and Adams (1977)
with the Chinese hamster V79-379A cell
line in spinner cultures. Enhanced cyto-
toxicity with other cancer chemothera-
peutic agents and hyperthermia has been
reported (Hahn et al., 1975; reviews by
Har-Kedar and Bleehen, 1976 and Dickson
and Suzangar, 1976). This may be due to
increased permeability of the cells to
drugs, or to inhibition of repair of poten-
tially lethal damage (Hahn et al., 1975).
Stratford and Adams (1977) have dis-
cussed their results with Ro-07-0582 in
terms of Arrhenius parameters, and have
concluded that the toxicity is a con-
sequence of cellular metabolism of the
drug, and that increased temperatures
result in its increased metabolism. We
do not have enough data from our in vivo
model to be able to make such an analysis.
It is also difficult to make a meaningful
quantitative comparison between the in
vitro and in vivo situation because of the
uncertainty about the relative proportion
of oxic and hypoxic cells in vivo. Our
results indicate cell killing considerably in
excess ofthat to be expected from previous
estimates of the hypoxic cell fraction in
the EMT6 tumour, which have been made
under similar conditions of anaesthesia
but at room temperature (Rockwell and
Kallman, 1973; Bleehen et al., unpub.).
This could indicate increased cytotoxicity
ofthe drug in our system on oxygenated as
well as hypoxic cells at the higher tempera-
tures. Changes in cellular 02 consump-
tion occur with rise in tumour temperature
(Bronk, 1976). This may then increase
the hypoxic cell fraction. The present
experiments do not distinguish between
these possibilities. We would expect that
the peak serum concentration of the drug
after a 1 mg/g i.p. dose should be about
5 mM (Adams and Fowler, 1976). This
concentration of drug may affect division
of aerobic V79-379A cells in vitro, but
does not affect their viability (Stratford
and Adams, 1977). Our preliminary data
with EMT6 cells in vitro also confirm this
observation.
Before the clinical significance of our
observations can be assessed, it will be
important to know whether or not there is
repair of the observed cell damage if the
tumours are left intact in vivo. Recovery
from potentially lethal damage has been
described for X-radiation (Little, et al.,
1973) and some cancer chemotherapeutic
agents (Hahn et al., 1973; Twentyman and
Bleehen, 1975). However, Hahn et al.
(1975) have reported that hyperthermia
will inhibit the repair of bleomycin
damage. The clinical use of the com-
bination of heat and hypoxic-cell sen-
sitizers will also depend on an improve-
ment in the therapeutic gain when the
effect on normal tissues is considered. We
are currently investigating these problems
in our experimental system.
We wish to thank Dr Carey Smithen of
Roche Products Ltd for supplies of
Ro-07-0582 and Dr G. E. Adams for
useful discussions. We are also grateful
to N. M. Maclaren for statistical advice.
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